Proud to Announce Our Partnership With GenomOncology and Belay Diagnostics - WeTrials

Dean Crowe: Rally Kids - Then and Now

Douglas Flora Shares Key Takeaways from NCODA’s Global Oncology Congress

ARCAGEN Trial at ESMO Sarcoma and Rare Cancers Congress 2026: Genomic Alterations and Access to Precision Therapies

Servier Acquires Day One Biopharmaceuticals for $2.5B, Betting on Tovorafenib and the Pediatric Glioma Frontier

Oncology News, Insights, Stories by OncoDaily

Martine Deprez
OncoDaily Magazine

Martine Deprez: Leading with Mathematics, Listening, and Social Responsibility

FDA Approves
Oncology Tech

FDA Approves Teclistamab Plus Daratumumab for Myeloma After ≥1 Prior Line — MajesTEC-3 Data Redefines the Standard of Care

Yvonne Awards
OncoDaily

Yvonne Awards 2026

Fear of Recurrence After Breast Radiotherapy

Yelena Janjigian: Science and Collaboration at ESMO 2026

Miriam Mutebi Breaks Silence on Myths and Challenges in Breast Cancer Care

Global DNA Manufacturing Market Set to Hit $21.8B as Asia-Pacific Accelerates

Servier Pharmaceuticals is Acquiring Day One Biopharmaceuticals - David K. Lee

Enfortumab Vedotin and Pembrolizumab vs Chemotherapy in Advanced Urothelial Carcinoma

Pretreatment KRAS-Mutant ctDNA Associated With Recurrence Risk After RFA for Colorectal Liver Metastases

Cervical Cancer 2026
Advances in The Immunotherapy of Cold Tumors
Advances in The Immunotherapy of Cold Tumors
OncoThon 2026
OncoDaily 100
Act 4 Children
Grand Rounds GI
OncoDaily Party: Berlin 2025
awards
awards
awards
awards
awards
awards

Voices
SIOG

Nutritional Strategies to Prevent Sarcopenia - SIOG

Celebrating Women in Science and Research - The Babak Lab

Jad M. Abdelsattar Collaborates With Breast Surgeons to Advance Patient Safety

Stephen V Liu: New Data from the ARTEMIS-001 Trial

Tedros Adhanom Ghebreyesus: WHO Activated an Emergency Task Team to Support Local Health Authorities in Ethiopia

Alex Rampotas: The Future of Blood Cancer Treatment

Naveen Pemmaraju: How to Optimize Lower-Intensity Triplet Therapy in AML

FDA Approvals
FDA approval BRAFTOVI

FDA Grants Full Approval of BRAFTOVI Combination Regimen in 1L Metastatic Colorectal Cancer

FDA Approves Combination Treatment of VENCLEXTA (venetoclax) and Acalabrutinib for Previously Untreated Patients With CLL

Monthly RYBREVANT FASPRO (Amivantamab) Approved by FDA for EGFR-Mutated NSCLC

PANOVA-3 Leads to FDA Approval of Optune Pax in Locally Advanced Pancreatic Cancer

Abbisko Therapeutics’ FGFR4 Inhibitor Irpagratinib Receives FDA Fast Track Designation in FGF19-Overexpressing Advanced HCC

Oncolytics Biotech Receives FDA Fast Track Designation for Pelareorep in 2L KRAS-Mutant MSS Metastatic Colorectal Cancer

FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutated NSCLC After TKI Therapy

OncoDaily 100
100 Most Influential CEOs

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

The 100 Most Influential People in Oncology in 2025 (Full List)

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2024

Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Top 100 Xfluencers in Breast Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Top 100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024

Celebrities and Cancer

OncoCalendar

2026 NCODA International Fall Summit

NCODA

28 Oct
NCODA International Fall Summit

Association of Breast Surgery (ABS) Conference 2026

The Association of Breast Surgery

08 Jun
Breast Surgery

Breast Cancer Now Healthcare Professionals Conference 2026

Breast Cancer Now

11 May
Breast Cancer

SIOP Webinar - Integrative Oncology in Pediatric Cancer Care

International Society of Paediatric Oncology (SIOP)

16 Mar
SIOP

Infantile Leukemia: Translating Protocol into Practice Through Clinical Experience - Resonance

Resonance

22 May
Leukemia

Immune-oncology
10 Must-Read Posts in Immuno-Oncology This Week

10 Must-Read Posts in Immuno-Oncology This Week

The Myth of Lifelong Immunotherapy: Is It Safe to Stop Treatment After Response?

10 Must-Read Posts in Immuno-Oncology This Week

Positive Topline Results from Phase 3 RINGSIDE Trial: Varegacestat Significantly Improves Outcomes in Desmoid Tumors

How Do Pharmacists Protect the Safety and Effectiveness of Immunotherapy?

10 Must-Read Posts in Immuno-Oncology This Week

10 Must-Read Posts in Immuno-Oncology This Week

OncoDaily TV
Sandy Duarte

Sandy Duarte: A Luminous Reflection on Illness, Faith, and Resilience in New Book I Am Alive

Accelerating Cancer Immunotherapy: Parker Institute & ASCO Launch Young Investigator Award

Accelerating Cancer Immunotherapy: Parker Institute & ASCO Launch Young Investigator Award

They Said It Would Never Work — Dr. George Demetri and the Drug That Changed GIST Forever

They Said It Would Never Work — Dr. George Demetri and the Drug That Changed GIST Forever

Empowering Oncologists

Empowering Oncologists: How service and volunteering advances one’s career?

ACT for Children: How Armenia is Changing Pediatric Oncology | Dr. Jennifer Lowe

ACT for Children: How Armenia is Changing Pediatric Oncology | Dr. Jennifer Lowe

When a Cancer Surgeon Becomes Minister of Health | Dr. Jigjidsuren Chinburen

When a Cancer Surgeon Becomes Minister of Health | Dr. Jigjidsuren Chinburen

60 questions about SCLC with Dr. Greg Kalemkerian Part 2

60 questions about SCLC with Dr. Greg Kalemkerian Part 2

What’s Next for Cancer Care in Armenia? Scott Howard

What’s Next for Cancer Care in Armenia? Scott Howard

The Breast Friends Podcast

Why Hasn’t Immunotherapy Consistently Delivered in HER2+ Disease? – The Breast Friends

Childhood Cancer

Saving One Million Children: WHO’s Global Initiative for Childhood Cancer with Dr. Catherine Lam

Jeffrey Bluestone

Inside the Mind of Jeffrey Bluestone: Lessons From a Lifetime in Immunology

Princess Dina Mired and Gevorg Tamamyan

Global Health Dialogues with Princess Dina Mired: Dr. Gevorg Tamamyan

Not To Miss
ESMO Congress 2026 - OncoDaily

Meet the Scientific Co-Chairs of the ESMO Congress 2026

OncoGrants Weekly: Top 10 OncoGrants to Apply for in 2026: Deadlines from March to June

International Women’s Day Highlights 2026: Honoring Women in Oncology

Oncology This Two Weeks: OncoDaily Weekly Feb 23 – March 8, 2026

HPV Awareness Day 2026: Why It Matters More Than Ever

15 Posts Not To Miss From 50th Simeonideios Lecture

15 Posts Not To Miss from ESGO 2026

OncoGrants
Melanoma Research Foundation (MRF) Established Investigator Award 2026

Melanoma Research Foundation (MRF) Established Investigator Award 2026

V Foundation V Scholar Grant 2026 (Adult Cancer — General Competition)

V Foundation V Scholar Grant 2026 (Adult Cancer — General Competition)

V Foundation Pediatric Cancer Research Awards 2026 (V Scholar + Translational + All-Star)

V Foundation Pediatric Cancer Research Awards 2026 (V Scholar + Translational + All-Star)

Conquer Cancer Young Investigator Award in Chronic Lymphocytic Leukemia 2026

Conquer Cancer Young Investigator Award in Chronic Lymphocytic Leukemia 2026

Conquer Cancer Young Investigator Award in Primary Brain Tumors 2026

Conquer Cancer Young Investigator Award in Primary Brain Tumors 2026

American Cancer Society Discovery Boost Grant (DBG)

American Cancer Society Discovery Boost Grant (DBG)

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
Colorectal Cancer

Colorectal Cancer: Epidemiology, Pathogenesis, Diagnosis, and Therapeutic Advances

Cholangiocarcinoma: Latest Risk Factors, Symptoms, Diagnosis, and 2025 Advanced Treatment Options for Bile Duct Cancer

Pheochromocytoma: Causes, Diagnosis, Treatment, and Breakthrough 2025 Advances in Management

Cervical Cancer: Symptoms, Causes, Stages, Diagnosis and Treatment

Craniopharyngioma: Symptoms, Diagnosis, Treatment, and 2025 Breakthroughs in Targeted Therapy and Precision Care

Malignant Schwannoma: Comprehensive Guide to Causes, Symptoms, Diagnosis, Treatment, Prognosis, and 2025 Advances in Schwannoma Care

Meningioma: Types, Symptoms, Diagnosis, Treatment, Malignancy Risk, and 2025 Breakthroughs

CancerWorld
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards

Oncologists
Uirá Maíra Resende

Uirá Maíra Resende

Oncologists Location Goiânia, Brazil
mahmoud hammad

Mahmoud Hammad

Oncologists Location Cairo, Egypt
Roberto Carmagnani Pestana

Roberto Carmagnani Pestana

Oncologists Location São Paulo, Brazil
Karima Oualla

Karima Oualla

Oncologists Location Fès, Morocco
Tezer Kutluk

M. Tezer Kutluk

Oncologists Location Ankara, Türkiye
Gabriele Todisco

Gabriele Todisco

Oncologists Location Milan, Italy
Rahat Ul Ain

Rahat Ul Ain

Oncologists Location Lahore, Pakistan
Chi-kong Li

Li Chi-kong

Oncologists Location Hong Kong, China

Oncology Drugs
Sacituzumab Tirumotecan

Sacituzumab Tirumotecan: What Patients Should Know About This Emerging Cancer Treatment

Sacituzumab Tirumotecan: Clinical Development, Mechanism, and Emerging Role in Modern Oncology

Lurbinectedin: What Patients Should Know

Lurbinectedin in Oncology: Mechanism, Clinical Data, Evolving Role, and Future Directions

Bemarituzumab: What Patients with Gastric Cancer Should Know

Bemarituzumab: Uses in Cancer, Side Effects, Dosages, Expectations and More

GSK5764227 (HS-20093): A Novel B7-H3 Targeted Antibody–Drug Conjugate Under Clinical Investigation

OncoDaily Magazine
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards

New Paper Alert
Neoadjuvant GOLP

Neoadjuvant GOLP in Resectable High-Risk Intrahepatic Cholangiocarcinoma: ZSAB-neoGOLP Trial

Sentinel Lymph Node Biospy

Sentinel Node Biopsy for Melanoma: Survival Benefit Confirmed in a Large Meta-Analysis

CAPItello-281 Trial

CAPItello-281 Trial at ASCO GU : Capivasertib Plus Abiraterone in PTEN-Deficient mHSPC

BCG

BCG and Beyond: Is Systemic Immunotherapy Progress or Overreach in BCG-Naïve NMIBC?

Rezatapopt

Rezatapopt Shows Early Activity in TP53 Y220C–Mutated Solid Tumors

CheckMate 743 Five-Year Update: Nivolumab Plus Ipilimumab Maintains Long-Term Survival Benefit in Unresectable Pleural Mesothelioma

CheckMate 743 Five-Year Update: Nivolumab Plus Ipilimumab Maintains Long-Term Survival Benefit in Unresectable Pleural Mesothelioma

OncoDaily Medical Journal

Pediatric Oncology

10.69690/ODMJ-001-0310-6131

Prevalence and Associated Factors of Cholelithiasis in Pediatric Sickle Cell Disease Patients at Qatif Health Network, Saudi Arabia
Original Research

Precision Oncology

10.69690/ODMJ-002-0226-7267

Unlocking Precision Medicine in Multiple Myeloma: Venetoclax and Novel Targeted Therapies
Review

Oncology Nursing

10.69690/ODMJ-002-0204-6423

Extracorporeal membrane oxygenation in the management of oncologic critical illness
Review

Radiation Oncology

10.69690/ODMJ-018-3101-6699

Comparative Evaluation of DIR-Based Auto-Adaptive, Manual, and Semi-Automated Contouring for Pelvic OARs in Cervical Cancer Adaptive Radiotherapy
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-6997

Validity of 18F FDG-PET/CT in the Detection of Bone Marrow Disease in Hodgkin's and Non-Hodgkin's Lymphoma
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-7103

Dosimetric Comparison of 5-, 7-, and 9-Field SIB-IMRT Plans in Prostate Cancer Using 100% Isodose-Based Target Evaluation
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-6652

Radiation‐induced Lung Toxicity: A Crucial Problem in Thoracic Radiotherapy
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-7089

Hippocampus Sparing for Patients Undergoing Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma in Morocco: A Dosimetric Study
Abstracts